Obermatt
See Similar Stocks →

Flags

Financial distress

ClearPoint Neuro

NAQ:CLPT · US18507C1036
Health Care Equipment & SuppliesSmall

360

18
Profit price78
Owner Earnings Yield1
Dividend Yield1
Price/Sales24
EV / Gross Profit17
Price/Book91
Return on Capital17
Cash Return on Capital22
Return on Equity7
EBIT Margin16
Gross Profitability36
Accruals57
Owner Earnings Margin18
Sales growth88
Profit growth25
Reinvestment97
Price momentum44
Debt load13
Refinancing29
Debt Payback1
Liquidity24
Analyst ratings100
Opinion Changes98
Price Target Upside63
Market mood73
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

ClearPoint Neuro doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded1998
Employees117
Websiteclearpointneuro.com
ISINUS18507C1036
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Artificial IntelligenceBiomedical EngineeringNeurologyCentral Nervous SystemNeuroscienceSurgeryBiotechnologyHealth CareHospitalMedical Device

Description

ClearPoint Neuro, Inc. is a commercial-stage medical device company. The company has deployed significant resources to fund its efforts to develop foundational capabilities for enabling magnetic resonance imaging (MRI) guided interventions, building…

Analysis

Weak and unloved

ClearPoint Neuro, Inc. is weak and unloved: below-average business metrics and a price that reflects that disappointment.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
88
2023202420252026

All-time high

88

Jun 2026

All-time low

1

Jan 2024

Average rank

34

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
24
3
30
15
Price/Earnings
81
40
40
40
Price/Book
91
7
19
40
Dividend Yield
1
1
1
1
Value (overall)
63
11
24
21

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare ClearPoint Neuro with its peers
Profound Medical
TOR:PRN
29
CountryCanada
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Hyperfine
NMQ:HYPR
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
IRadimed
NMQ:IRMD
64
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Fonar
NAQ:FONR
53
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Stryker
NYQ:SYK
60
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Alphatec
NSQ:ATEC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →